Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.

Autin P, Blanquart C, Fradin D.

Cancers (Basel). 2019 Oct 10;11(10). pii: E1530. doi: 10.3390/cancers11101530. Review.

2.

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Samimi M, Benlalam H, Aumond P, Gaboriaud P, Fradin D, Kervarrec T, Florenceau L, Vignard V, Blom A, Touzé A, Gervois N, Labarriere N.

Cell Immunol. 2019 Oct;344:103961. doi: 10.1016/j.cellimm.2019.103961. Epub 2019 Aug 1.

PMID:
31472938
3.

Correction to: Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene.

Le Stunff C, Castell AL, Todd N, Mille C, Belot MP, Frament N, Brailly-Tabard S, Benachi A, Fradin D, Bougnères P.

Clin Epigenetics. 2018 Jun 4;10:74. doi: 10.1186/s13148-018-0506-z. eCollection 2018.

4.

Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene.

Le Stunff C, Castell AL, Todd N, Mille C, Belot MP, Frament N, Brailly-Tabard S, Benachi A, Fradin D, Bougnères P.

Clin Epigenetics. 2018 Apr 19;10:57. doi: 10.1186/s13148-018-0489-9. eCollection 2018. Erratum in: Clin Epigenetics. 2018 Jun 4;10:74.

5.

The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature.

Ben-Avraham D, Govindaraju DR, Budagov T, Fradin D, Durda P, Liu B, Ott S, Gutman D, Sharvit L, Kaplan R, Bougnères P, Reiner A, Shuldiner AR, Cohen P, Barzilai N, Atzmon G.

Sci Adv. 2017 Jun 16;3(6):e1602025. doi: 10.1126/sciadv.1602025. eCollection 2017 Jun.

6.

Genome-Wide Methylation Analysis Identifies Specific Epigenetic Marks In Severely Obese Children.

Fradin D, Boëlle PY, Belot MP, Lachaux F, Tost J, Besse C, Deleuze JF, De Filippo G, Bougnères P.

Sci Rep. 2017 Apr 7;7:46311. doi: 10.1038/srep46311.

7.

Role of DNA methylation at the placental RTL1 gene locus in type 1 diabetes.

Belot MP, Nadéri K, Mille C, Boëlle PY, Benachi A, Bougnères P, Fradin D.

Pediatr Diabetes. 2017 May;18(3):178-187. doi: 10.1111/pedi.12387. Epub 2016 May 13.

PMID:
27174469
8.

A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens.

Chalopin B, Florenceau L, Fradin D, Labarrière N, Moreau-Aubry A.

Melanoma Res. 2015 Aug;25(4):279-83. doi: 10.1097/CMR.0000000000000167.

PMID:
25968572
9.

Global positioning system use in the community to evaluate improvements in walking after revascularization: a prospective multicenter study with 6-month follow-up in patients with peripheral arterial disease.

Gernigon M, Le Faucheur A, Fradin D, Noury-Desvaux B, Landron C, Mahe G, Abraham P.

Medicine (Baltimore). 2015 May;94(18):e838. doi: 10.1097/MD.0000000000000838.

10.

The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.

Ouni M, Belot MP, Castell AL, Fradin D, Bougnères P.

Pharmacogenomics J. 2016 Feb;16(1):102-6. doi: 10.1038/tpj.2015.26. Epub 2015 Apr 14.

11.

The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Ouni M, Gunes Y, Belot MP, Castell AL, Fradin D, Bougnères P.

Clin Epigenetics. 2015 Mar 13;7:22. doi: 10.1186/s13148-015-0062-8. eCollection 2015.

12.

Hypomethylation of the promoter of the catalytic subunit of protein phosphatase 2A in response to hyperglycemia.

Tros F, Meirhaeghe A, Hadjadj S, Amouyel P, Bougnères P, Fradin D.

Physiol Rep. 2014 Jul 16;2(7). pii: e12076. doi: 10.14814/phy2.12076.

13.

β cells keep bad epigenetic memories of palmitate.

Fradin D, Bougnères P.

BMC Med. 2014 Jun 23;12:104. doi: 10.1186/1741-7015-12-104.

14.

CpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset.

Belot MP, Fradin D, Mai N, Le Fur S, Zélénika D, Kerr-Conte J, Pattou F, Lucas B, Bougnères P.

PLoS One. 2013 Jul 12;8(7):e68093. doi: 10.1371/journal.pone.0068093. Print 2013.

15.

XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genes.

Le May N, Fradin D, Iltis I, Bougnères P, Egly JM.

Mol Cell. 2012 Aug 24;47(4):622-32. doi: 10.1016/j.molcel.2012.05.050. Epub 2012 Jul 5.

16.

Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes.

Fradin D, Le Fur S, Mille C, Naoui N, Groves C, Zelenika D, McCarthy MI, Lathrop M, Bougnères P.

PLoS One. 2012;7(5):e36278. doi: 10.1371/journal.pone.0036278. Epub 2012 May 2.

17.

T2DM: Why Epigenetics?

Fradin D, Bougnères P.

J Nutr Metab. 2011;2011:647514. doi: 10.1155/2011/647514. Epub 2011 Nov 3.

18.

Personalized epigenomic signatures that are stable over time and covary with body mass index.

Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T, Eiriksdottir G, Harris TB, Launer L, Gudnason V, Fallin MD.

Sci Transl Med. 2010 Sep 15;2(49):49ra67. doi: 10.1126/scitranslmed.3001262. Erratum in: Sci Transl Med. 2011 Jan 12;3(65):65er1.

19.

Parent-of-origin effects in autism identified through genome-wide linkage analysis of 16,000 SNPs.

Fradin D, Cheslack-Postava K, Ladd-Acosta C, Newschaffer C, Chakravarti A, Arking DE, Feinberg A, Fallin MD.

PLoS One. 2010 Sep 2;5(9). pii: e12513. doi: 10.1371/journal.pone.0012513.

21.

Three common variants of LEP, NPY1R and GPR54 show no association with age at menarche.

Rothenbuhler A, Lotton C, Fradin D.

Horm Res. 2009;71(6):331-5. doi: 10.1159/000223417. Epub 2009 Jun 6.

PMID:
19506390
22.
23.
24.
25.

Identification of distinct quantitative trait Loci affecting length or weight variability at birth in humans.

Fradin D, Heath S, Lepercq J, Lathrop M, Bougnères P.

J Clin Endocrinol Metab. 2006 Oct;91(10):4164-70. Epub 2006 Jul 18.

PMID:
16849411
26.

Weight-adjusted genome scan analysis for mapping quantitative trait Loci for menarchal age.

Rothenbuhler A, Fradin D, Heath S, Lefevre H, Bouvattier C, Lathrop M, Bougnères P.

J Clin Endocrinol Metab. 2006 Sep;91(9):3534-7. Epub 2006 Jun 27.

PMID:
16804047
27.

'Non-Mendelian' genetics of fetal growth.

Fradin D, Boileau P, Lepercq J, Bougnères P.

J Endocrinol Invest. 2006;29(1 Suppl):11-5. Review.

PMID:
16615301
28.

Association of Kir6.2 and INS VNTR variants with glucose homeostasis in young obese.

Le Fur S, Fradin D, Boileau P, Bougnères P.

Physiol Genomics. 2005 Aug 11;22(3):398-401. Epub 2005 Jun 14.

PMID:
15956217
29.

Preliminary experimental results of a new resorbable biomaterial as pericardial substitute.

Fradin D, Causs T, Rabaud M, de Mascarel A, Fontan F.

J Thorac Cardiovasc Surg. 1993 Feb;105(2):364-5. No abstract available.

PMID:
8429665
30.

A new biodegradable elastin-fibrin material; its use in urological, digestive and cardiovascular surgery.

Rabaud M, Elie JY, Lefebvre F, Ducassou D, Mettetal P, Le Guillou M, Collet D, Périssat J, Fradin D, Fontan F.

J Biomater Appl. 1992 Jul;7(1):20-46.

PMID:
1432577
31.

[Villous tumors of the duodenum. Apropos of 2 cases, a review of the literature].

Pailler JL, Brissiaud JC, Mianne D, Fradin D.

Chirurgie. 1988;114(7-8):628-36. Review. French. No abstract available.

PMID:
3072165
32.

Split-mode unstable resonator.

Freiberg RJ, Fradin DW, Chenausky PP.

Appl Opt. 1977 May 1;16(5):1192-6. doi: 10.1364/AO.16.001192.

PMID:
20168676
33.

Confirmation of an Electron Avalanche Causing Laser-induced Bulk Damage at 1.06 microm.

Fradin DW, Yablonovitch E, Bass M.

Appl Opt. 1973 Apr 1;12(4):700-9. doi: 10.1364/AO.12.000700.

PMID:
20125376

Supplemental Content

Loading ...
Support Center